Repaglinide
At a glance
- Drug Originator Boehringer Ingelheim
- Drug Licenced by Daiichi Sankyo Europe; Fournier Pharma; Novo Nordisk; Shionogi Pharma; Sumitomo Pharma
- Drug Class Antihyperglycaemics; Carbamates; Piperidines; Small molecules
- Mechanism of Action Insulinotropin agonists; Potassium channel antagonists
- USA Patent Applicants GEMINI LABS LLC
- USA Patents 7
- NDAs 1
- Patent Applications 3,741
Table of Contents
Disclaimer